Johnson & Johnson看到投资者的关键动作,因为它报告Q1收入丰厚,并提高了年度预测。 Johnson & Johnson saw key investor moves as it reported strong Q1 earnings and raised its yearly forecast.

联合资本金融顾问在Johnson & Johnson公司(JNJ)的股权增加了10.1%,获得了价值4 220万美元的额外股份。 United Capital Financial Advisors increased its stake in Johnson & Johnson (JNJ) by 10.1%, acquiring additional shares worth $42.2 million. 与此同时,Operose顾问公司将其股份减少了33%,出售股票。 Meanwhile, Operose Advisors reduced its stake by 33%, selling shares. JNJ报告说,Q1结果强劲,超过了收入和收入预测,提高了全年销售前景。 JNJ reported strong Q1 results, exceeding revenue and earnings forecasts, and raised its full-year sales outlook. 该公司还完成了对宫内治疗的收购,并计划对美国进行更多的投资。 其股票的评级是“中价购买”,目标价格为171.50美元。 The company also completed its acquisition of Intra-Cellular Therapies and plans to invest more in the U.S. Its stock has a "Moderate Buy" rating with a target price of $171.50.